Bill > HB1103

This bill mandates that public institutions of higher education in Texas develop and implement comprehensive policies for managing opioid antagonists (medications like Narcan that can reverse opioid overdoses) in campus residence halls. Specifically, each institution must create a policy ensuring opioid antagonists are available in residence halls, with clear protocols for acquiring, storing, and administering these devices. Resident advisors (RAs) will be required to undergo mandatory annual training on recognizing overdose symptoms, properly administering opioid antagonists, and following emergency procedures. The bill allows physicians to prescribe opioid antagonists directly to institutions under standing orders that do not require patient-specific identification, and pharmacists can dispense these medications to institutions without user-specific details. Importantly, the bill provides broad legal immunity for anyone acting in good faith under these provisions, protecting RAs, employees, and institutions from civil or criminal liability when responding to potential overdose situations. Institutions must report certain details about each opioid antagonist administration to the prescribing physician and include the policy in student handbooks and on their websites. The policy must be implemented by the fall semester of 2026, with the act taking effect immediately if it receives a two-thirds vote in the Texas legislature, or otherwise on September 1, 2025.

Education

https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB1103